AKT1 and leukemia: In contrast to RPs, most ADRs inhibited γH2AX and p-4EBP1 and activated p-AKT and p-STAT5, a signature of cell survival signaling in leukemia cells that, while demonstrative of the ability of the approach to identify contrasting mechanisms, is not ideal for cancer research.